Khaitan & Co advised India Resurgence Fund on the deal. India Resurgence Fund completed the acquisition of active pharmaceutical ingredients (API) and contract research and manufacturing services...
India Resurgence’s Acquisition of API and CRAMS Business of Ind Swift Laboratories
MoneyView’s Investment Round
Khaitan & Co. advised Apis Partners in the deal. Apis Partners proposed a minority investment in Whizdm Innovations Private Limited (d.b.a MoneyView). Apis led the Series...